Octagon Capital Advisors LP Quant / Systematic

Location: New York, NY

CIK: 0001839435 · Show all filings

Period: Q2 2021 (← Previous) (Next →)

Filing Date: Aug 16, 2021

Total Value: $483M (100.0% shares, 0.0% debt)

Holdings (34)

APLS APELLIS PHARMACEUTICALS INC 16.4%

Value $79.4M Shares 1,256,265 Est. Cost $47.54 Unrealized +8.5%

NBP I MAB 16.4%

Value $79.18M Shares 943,156 Est. Cost $63.37 Unrealized —

— CURIS INC 6.0%

Value $28.91M Shares 3,582,629 Est. Cost $8.14 Unrealized —

BBIO BRIDGEBIO PHARMA INC 4.8%

Value $23.22M Shares 380,928 Est. Cost $57.11 Unrealized 0.0%

RCUS ARCUS BIOSCIENCES INC 4.3%

Value $20.87M Shares 760,164 Est. Cost $27.66 Unrealized +3.3%

FDMT 4D MOLECULAR THERAPEUTICS IN 4.1%

Value $20.02M Shares 831,267 Est. Cost $35.47 Unrealized -13.7%

ZLAB ZAI LAB LTD 4.0%

Value $19.35M Shares 109,335 Est. Cost $176.99 Unrealized —

CLDX CELLDEX THERAPEUTICS INC NEW 3.9%

Value $18.77M Shares 561,398 Est. Cost $18.00 Unrealized +52.5%

VERA VERA THERAPEUTICS INC 3.1%

Value $15.01M Shares 1,132,671 Est. Cost $15.54 Unrealized 0.0%

— ACCELERON PHARMA INC 2.9%

Value $14.1M Shares 112,363 Est. Cost $127.94 Unrealized —

ARVN ARVINAS INC 2.8%

Value $13.74M Shares 178,500 Est. Cost $34.48 Unrealized +101.3%

DYN DYNE THERAPEUTICS INC 2.5%

Value $12.28M Shares 583,649 Est. Cost $19.71 Unrealized -4.6%

IPSC CENTURY THERAPEUTICS INC 2.5%

Value $11.84M Shares 403,523 Est. Cost $25.37 Unrealized 0.0%

GOSS GOSSAMER BIO INC 2.4%

Value $11.47M Shares 1,413,138 Est. Cost $9.85 Unrealized -12.0%

RNAM AVIDITY BIOSCIENCES INC 2.3%

Value $11.04M Shares 446,641 Est. Cost $28.99 Unrealized -19.7%

STOK STOKE THERAPEUTICS INC 2.1%

Value $9.991M Shares 296,822 Est. Cost $35.35 Unrealized 0.0%

— AMBRX BIOPHARMA INC 1.8%

Value $8.82M Shares 450,000 Est. Cost $19.60 Unrealized —

PMVP PMV PHARMACEUTICALS INC 1.8%

Value $8.54M Shares 250,000 Est. Cost $39.23 Unrealized -14.9%

— CONNECT BIOPHARMA HLDGS LTD 1.5%

Value $7.294M Shares 373,492 Est. Cost $18.50 Unrealized —

TSHA TAYSHA GENE THERAPIES INC 1.4%

Value $6.793M Shares 320,440 Est. Cost $21.54 Unrealized +7.0%

CRDF CARDIFF ONCOLOGY INC 1.4%

Value $6.535M Shares 982,753 Est. Cost $14.50 Unrealized -41.5%

— IKENA ONCOLOGY INC 1.2%

Value $5.616M Shares 400,000 Est. Cost $28.25 Unrealized —

GLUE MONTE ROSA THERAPEUTICS INC 1.1%

Value $5.404M Shares 238,045 Est. Cost $20.37 Unrealized 0.0%

DSGN DESIGN THERAPEUTICS INC 1.0%

Value $4.973M Shares 250,000 Est. Cost $31.14 Unrealized -19.0%

— PROMETHEUS BIOSCIENCES INC 1.0%

Value $4.912M Shares 200,000 Est. Cost $18.26 Unrealized —

KYMR KYMERA THERAPEUTICS INC 1.0%

Value $4.85M Shares 100,000 Est. Cost $43.41 Unrealized 0.0%

— MERUS N V 0.9%

Value $4.36M Shares 206,927 Est. Cost $20.90 Unrealized —

— IVERIC BIO INC 0.9%

Value $4.291M Shares 680,036 Est. Cost $6.91 Unrealized —

MLTX HELIX ACQUISITION CORP 0.9%

Value $4.132M Shares 400,000 Est. Cost $11.37 Unrealized —

RVMD REVOLUTION MEDICINES INC 0.8%

Value $4.004M Shares 126,136 Est. Cost $39.54 Unrealized -11.7%

— NGM BIOPHARMACEUTICALS INC 0.8%

Value $3.944M Shares 200,000 Est. Cost $29.53 Unrealized —

— KRONOS BIO INC 0.7%

Value $3.501M Shares 146,173 Est. Cost $29.87 Unrealized —

— JIYA ACQUISITION CORP 0.6%

Value $2.982M Shares 300,000 Est. Cost $10.30 Unrealized —

EWTX EDGEWISE THERAPEUTICS INC 0.6%

Value $2.666M Shares 125,000 Est. Cost $32.43 Unrealized -15.7%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
APLS	APELLIS PHARMACEUTICALS INC	1,256,265	$79.4M	16.4%	$47.54	+8.5%	COM	03753U106
NBP	I MAB	943,156	$79.18M	16.4%	$63.37	—	SPONSORED ADS	44975P103
—	CURIS INC	3,582,629	$28.91M	6.0%	$8.14	—	COM NEW	231269200
BBIO	BRIDGEBIO PHARMA INC	380,928	$23.22M	4.8%	$57.11	0.0%	COM	10806X102
RCUS	ARCUS BIOSCIENCES INC	760,164	$20.87M	4.3%	$27.66	+3.3%	COM	03969F109
FDMT	4D MOLECULAR THERAPEUTICS IN	831,267	$20.02M	4.1%	$35.47	-13.7%	COM	35104E100
ZLAB	ZAI LAB LTD	109,335	$19.35M	4.0%	$176.99	—	ADR	98887Q104
CLDX	CELLDEX THERAPEUTICS INC NEW	561,398	$18.77M	3.9%	$18.00	+52.5%	COM NEW	15117B202
VERA	VERA THERAPEUTICS INC	1,132,671	$15.01M	3.1%	$15.54	0.0%	CL A	92337R101
—	ACCELERON PHARMA INC	112,363	$14.1M	2.9%	$127.94	—	COM	00434H108
ARVN	ARVINAS INC	178,500	$13.74M	2.8%	$34.48	+101.3%	COM	04335A105
DYN	DYNE THERAPEUTICS INC	583,649	$12.28M	2.5%	$19.71	-4.6%	COM	26818M108
IPSC	CENTURY THERAPEUTICS INC	403,523	$11.84M	2.5%	$25.37	0.0%	COM	15673T100
GOSS	GOSSAMER BIO INC	1,413,138	$11.47M	2.4%	$9.85	-12.0%	COM	38341P102
RNAM	AVIDITY BIOSCIENCES INC	446,641	$11.04M	2.3%	$28.99	-19.7%	COM	05370A108
STOK	STOKE THERAPEUTICS INC	296,822	$9.991M	2.1%	$35.35	0.0%	COM	86150R107
—	AMBRX BIOPHARMA INC	450,000	$8.82M	1.8%	$19.60	—	SPONSORED ADS	02290A102
PMVP	PMV PHARMACEUTICALS INC	250,000	$8.54M	1.8%	$39.23	-14.9%	COM	69353Y103
—	CONNECT BIOPHARMA HLDGS LTD	373,492	$7.294M	1.5%	$18.50	—	ADS	207523101
TSHA	TAYSHA GENE THERAPIES INC	320,440	$6.793M	1.4%	$21.54	+7.0%	COM SHS	877619106
CRDF	CARDIFF ONCOLOGY INC	982,753	$6.535M	1.4%	$14.50	-41.5%	COM	14147L108
—	IKENA ONCOLOGY INC	400,000	$5.616M	1.2%	$28.25	—	COM	45175G108
GLUE	MONTE ROSA THERAPEUTICS INC	238,045	$5.404M	1.1%	$20.37	0.0%	COM	61225M102
DSGN	DESIGN THERAPEUTICS INC	250,000	$4.973M	1.0%	$31.14	-19.0%	COM	25056L103
—	PROMETHEUS BIOSCIENCES INC	200,000	$4.912M	1.0%	$18.26	—	COM	74349U108
KYMR	KYMERA THERAPEUTICS INC	100,000	$4.85M	1.0%	$43.41	0.0%	COM	501575104
—	MERUS N V	206,927	$4.36M	0.9%	$20.90	—	COM	N5749R100
—	IVERIC BIO INC	680,036	$4.291M	0.9%	$6.91	—	COM	46583P102
MLTX	HELIX ACQUISITION CORP	400,000	$4.132M	0.9%	$11.37	—	COM CL A	G4444C102
RVMD	REVOLUTION MEDICINES INC	126,136	$4.004M	0.8%	$39.54	-11.7%	COM	76155X100
—	NGM BIOPHARMACEUTICALS INC	200,000	$3.944M	0.8%	$29.53	—	COM	62921N105
—	KRONOS BIO INC	146,173	$3.501M	0.7%	$29.87	—	COM	50107A104
—	JIYA ACQUISITION CORP	300,000	$2.982M	0.6%	$10.30	—	COM CL A	47760M102
EWTX	EDGEWISE THERAPEUTICS INC	125,000	$2.666M	0.6%	$32.43	-15.7%	COM	28036F105